JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $221,861 | -87.9% | 119,925 | -92.8% | 0.00% | – |
| Q4 2022 | $1,840,297 | -53.1% | 1,657,925 | -1.2% | 0.00% | -100.0% |
| Q3 2022 | $3,928,000 | -20.4% | 1,678,448 | +3.0% | 0.00% | 0.0% |
| Q2 2022 | $4,937,000 | -52.4% | 1,629,922 | +6.8% | 0.00% | 0.0% |
| Q1 2022 | $10,363,000 | +3412.9% | 1,526,288 | +4212.4% | 0.00% | – |
| Q4 2021 | $295,000 | +68.6% | 35,393 | +49.3% | 0.00% | – |
| Q3 2021 | $175,000 | -71.6% | 23,705 | -73.9% | 0.00% | – |
| Q2 2021 | $617,000 | +254.6% | 90,731 | +435.1% | 0.00% | – |
| Q1 2021 | $174,000 | -28.4% | 16,956 | -51.2% | 0.00% | – |
| Q4 2020 | $243,000 | -12.6% | 34,729 | +2.1% | 0.00% | – |
| Q3 2020 | $278,000 | +65.5% | 33,999 | +39.8% | 0.00% | – |
| Q2 2020 | $168,000 | -20.0% | 24,328 | -45.0% | 0.00% | – |
| Q1 2020 | $210,000 | -49.3% | 44,258 | -6.5% | 0.00% | – |
| Q4 2019 | $414,000 | +172.4% | 47,360 | +3.6% | 0.00% | – |
| Q3 2019 | $152,000 | +111.1% | 45,733 | +212.2% | 0.00% | – |
| Q2 2019 | $72,000 | -28.7% | 14,650 | -9.4% | 0.00% | – |
| Q1 2019 | $101,000 | -74.9% | 16,162 | -86.5% | 0.00% | – |
| Q4 2018 | $403,000 | +27.1% | 119,756 | +145.6% | 0.00% | – |
| Q3 2018 | $317,000 | -65.4% | 48,753 | -59.2% | 0.00% | – |
| Q2 2018 | $915,000 | +7.8% | 119,525 | +214.5% | 0.00% | – |
| Q1 2018 | $849,000 | +39.9% | 38,007 | -20.3% | 0.00% | – |
| Q4 2017 | $607,000 | -59.4% | 47,690 | -50.3% | 0.00% | – |
| Q3 2017 | $1,494,000 | +758.6% | 95,921 | +676.1% | 0.00% | – |
| Q2 2017 | $174,000 | -68.7% | 12,360 | -51.0% | 0.00% | – |
| Q1 2017 | $556,000 | – | 25,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |